Correlation Between Summit Therapeutics and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Therapeutics PLC and Fate Therapeutics, you can compare the effects of market volatilities on Summit Therapeutics and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Fate Therapeutics.
Diversification Opportunities for Summit Therapeutics and Fate Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Summit and Fate is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Summit Therapeutics and Fate Therapeutics
Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 0.48 times more return on investment than Fate Therapeutics. However, Summit Therapeutics PLC is 2.1 times less risky than Fate Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.17 per unit of risk. If you would invest 1,919 in Summit Therapeutics PLC on September 25, 2024 and sell it today you would lose (52.00) from holding Summit Therapeutics PLC or give up 2.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 95.24% |
Values | Daily Returns |
Summit Therapeutics PLC vs. Fate Therapeutics
Performance |
Timeline |
Summit Therapeutics PLC |
Fate Therapeutics |
Summit Therapeutics and Fate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Summit Therapeutics and Fate Therapeutics
The main advantage of trading using opposite Summit Therapeutics and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.Summit Therapeutics vs. Fate Therapeutics | Summit Therapeutics vs. Caribou Biosciences | Summit Therapeutics vs. Karyopharm Therapeutics | Summit Therapeutics vs. X4 Pharmaceuticals |
Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |